Home

Kamada Ltd. - Ordinary Shares (KMDA)

6.6100
-0.1800 (-2.65%)

Kamada Ltd is a biopharmaceutical company that specializes in the development and commercialization of innovative therapeutics for rare and serious diseases

The company focuses on producing protein-based drugs, particularly in the fields of immunology and respiratory medicine, utilizing its proprietary technology platforms. By developing therapies that address unmet medical needs, Kamada aims to improve the quality of life for patients while advancing healthcare solutions in specialized treatment areas. The company actively engages in partnerships and collaborations to enhance its research and development efforts, striving to bring new and effective treatments to market.

SummaryNewsPress ReleasesChartHistoricalFAQ
How Kamada (NASDAQ: KMDA) Is Transforming Its Strategic Focus Into Commercial Growth
By JE Insights, Benzinga
Via TheNewswire.com · February 28, 2025
How Kamada (NASDAQ: KMDA) Is Transforming Its Strategic Focus Into Commercial Growth
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 28, 2025
Kamada Ltd. (NASDAQ: KMDA) Records 52-Week High Wednesday Morning
Shares of Kamada Ltd. (NASDAQKMDA) traded at a new 52-week high today and are currently trading at $5.29. So far today, approximately 287.54k shares have been exchanged, as compared to an average 30-day volume of 20,106 shares.
Via Investor Brand Network · May 24, 2023